Cases
ReWalk Robotics, Ltd. (NASDAQ: RWLK)
Securities Class Action
Overview
Overview
- Date:
- 1/27/2017
- Company Name:
- ReWalk Robotics, Ltd.
- Stock Symbol:
- RWLK
- Class Period:
- FROM 9/9/2014 TO 1/24/2017
- Status:
- Closed/Complete
- Court:
- U.S. District Court: Northern California
NEW YORK, January 27, 2017 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who acquired ReWalk Robotics, Ltd. (NASDAQ: RWLK) securities between September 9, 2014 and January 24, 2017 (the “Class Period”).
The Complaint alleges that defendants caused ReWalk to issue its Registration Statement and Prospectus in connection with the IPO that contained materially misleading statements and/or omitted material information in violation of Sections 11, 12 and 15 of the Securities Act of 1933. The Complaint alleges that the Registration Statement and Prospectus failed to disclose that ReWalk was unprepared and/or unable to comply with applicable "special controls" requirements or to provide the FDA with a postmarket surveillance study as required by the FDA for the Company to maintain ongoing sales of its products. The Complaint also names as defendants certain of the Company's officers and directors, the underwriters of the IPO and certain venture capital firms with significant holdings in the Company for violations of Sections 12 and 15 of the Securities Act of 1933.
If you acquired ReWalk securities during the Class Period, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
The Complaint alleges that defendants caused ReWalk to issue its Registration Statement and Prospectus in connection with the IPO that contained materially misleading statements and/or omitted material information in violation of Sections 11, 12 and 15 of the Securities Act of 1933. The Complaint alleges that the Registration Statement and Prospectus failed to disclose that ReWalk was unprepared and/or unable to comply with applicable "special controls" requirements or to provide the FDA with a postmarket surveillance study as required by the FDA for the Company to maintain ongoing sales of its products. The Complaint also names as defendants certain of the Company's officers and directors, the underwriters of the IPO and certain venture capital firms with significant holdings in the Company for violations of Sections 12 and 15 of the Securities Act of 1933.
If you acquired ReWalk securities during the Class Period, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.